Arrowstreet Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06B | Buy |
|
|||||
2025
Q1 | $954M | Buy |
|
|||||
2024
Q4 | $793M | Buy |
|
|||||
2024
Q3 | $573M | Buy |
|
|||||
2024
Q2 | $428M | Buy |
|
|||||
2024
Q1 | $389M | Buy |
|
|||||
2023
Q4 | $257M | Buy |
|
|||||
2023
Q3 | $92.8M | Buy |
|
|||||
2023
Q2 | $14.5M | Buy |
|
|||||
2023
Q1 | $5.69M | Buy |
|
|||||
2022
Q4 | $1.49M | Buy |
|
|||||
2022
Q3 | $360K | Sell |
|
|||||
2022
Q2 | $2.94M | Sell |
|
|||||
2022
Q1 | $130M | Sell |
|
|||||
2021
Q4 | $171M | Sell |
|
|||||
2021
Q3 | $158M | Buy |
|
|||||
2021
Q2 | $44.1M | Buy |
|
|||||
2021
Q1 | $7.68M | Buy |
|
|||||
2020
Q4 | $1.34M | Sell |
|
|||||
2020
Q3 | $74.6M | Buy |
|
|||||
2020
Q2 | $56.7M | Buy |
|
|||||
2020
Q1 | $16M | Buy |
|
|||||
2019
Q4 | $978K | Buy |
|
|||||
2019
Q3 | $866K | Buy |
|
|||||
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $7.38M | Buy |
|
|||||
2018
Q4 | $3.21M | Sell |
|
|||||
2018
Q3 | $95.2M | Sell |
|
|||||
2018
Q2 | $244M | Sell |
|
|||||
2018
Q1 | $405M | Buy |
|
|||||
2017
Q4 | $322M | Buy |
|
|||||
2017
Q3 | $195M | Buy |
|
|||||
2017
Q2 | $56.3M | Buy |
|
|||||
2017
Q1 | $606K | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $14.8M | Sell |
|
|||||
2016
Q2 | $15.7M | Sell |
|
|||||
2016
Q1 | $69.6M | Buy |
|
|||||
2015
Q4 | $51.9M | Sell |
|
|||||
2015
Q3 | $96.1M | Buy |
|
|||||
2015
Q2 | $87.1M | Buy |
|
|||||
2015
Q1 | $87.6M | Buy |
|
|||||
2014
Q4 | $59.7M | Buy |
|
|||||
2014
Q3 | $29.9M | Buy |
|
|||||
2014
Q2 | – | Sell |
|
|||||
2014
Q1 | $521K | Sell |
|
|||||
2013
Q4 | $46.3M | Buy |
|